Shah TT, Peters M, Eldred-Evans D, Miah S, Yap T, Faure-Walker NA, et al. Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry. Eur Urol. 2019;76:98–105.

Article  PubMed  Google Scholar 

Reddy D, Peters M, Shah TT, van Son M, Tanaka MB, Huber PM, et al. Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol. 2022;81:407–13. https://doi.org/10.1016/j.eururo.2022.01.005.

Article  PubMed  Google Scholar 

Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl J Med. 2023;388:1547–58. https://doi.org/10.1056/NEJMoa2214122.

Article  PubMed  Google Scholar 

Connor MJ, Gorin MA, Ahmed HU, Nigam R. Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI. Prostate Cancer Prostat Dis. 2020;23:232–43. https://doi.org/10.1038/s41391-020-0206-6.

Article  CAS  Google Scholar 

Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, et al. Surveillance after prostate focal therapy. World J Urol. 2019;37:397–407. https://doi.org/10.1007/s00345-018-2363-y.

Article  PubMed  Google Scholar 

Postema AW, De Reijke TM, Ukimura O, Van den Bos W, Azzouzi AR, Barret E, et al. Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project. World J Urol. 2016;34:1373–82. https://doi.org/10.1007/s00345-016-1782-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lebastchi AH, George AK, Polascik TJ, Coleman J, de la Rosette J, Turkbey B, et al. Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus. Eur Urol. 2020;78:371–8. https://doi.org/10.1016/j.eururo.2020.05.018.

Article  PubMed  PubMed Central  Google Scholar 

van den Bos W, Muller BG, Ahmed H, Bangma CH, Barret E, Crouzet S, et al. Focal therapy in prostate cancer: international multidisciplinary consensus on trial design. Eur Urol. 2014;65:1078–83. https://doi.org/10.1016/j.eururo.2014.01.001.

Article  PubMed  Google Scholar 

Mottet N, Cornford P, van den Bergh RCN, Briers E, Eberli D, De Meerleer G, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer 2023. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6. Available from: https://uroweb.org/guidelines/prostate-cancer

Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up. J Urol. 2022;208:19–25.

Article  PubMed  Google Scholar 

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, et al. Focal therapy: patients, interventions, and outcomes-a report from a consensus meeting. Eur Urol. 2015;67:771–7. https://doi.org/10.1016/j.eururo.2014.09.018.

Article  PubMed  PubMed Central  Google Scholar 

van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, et al. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World J Urol. 2019;37:2147–53. https://doi.org/10.1007/s00345-019-02636-7.

Article  PubMed  PubMed Central  Google Scholar 

Marra G, Soeterik T, Oreggia D, Tourinho-Barbosa R, Moschini M, Filippini C, et al. Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance. Eur Urol Focus. 2022;8:701–9. https://doi.org/10.1016/j.euf.2021.04.008.

Article  PubMed  Google Scholar 

Kayano PP, Klotz L. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Curr Opin Urol. 2021;31:49–57. https://doi.org/10.1097/MOU.0000000000000838.

Article  PubMed  Google Scholar 

Breda A, Anterasian C, Belldegrun A. Management and outcomes of tumor recurrence after focal ablation renal therapy. J Endourol. 2010;24:749–52. https://doi.org/10.1089/end.2009.0658.

Article  PubMed  PubMed Central  Google Scholar 

Scheltema MJ, Geboers B, Blazevski A, Doan P, Katelaris A, Agrawal S, et al. Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer. BJU Int. 2023;131:6–13. https://doi.org/10.1111/bju.15946.

Article  PubMed  Google Scholar 

Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, et al. Robot-assisted radical prostatectomy after focal therapy: oncological, functional outcomes and predictors of recurrence. Eur Urol. 2019;76:27–30. https://doi.org/10.1016/j.eururo.2019.03.007.

Article  PubMed  Google Scholar 

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, et al. Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium. Eur Urol. 2019;75:523–31. https://doi.org/10.1016/j.eururo.2018.10.025.

Article  PubMed  Google Scholar 

Jansen BHE, van Leeuwen PJ, Wondergem M, van der Sluis TM, Nieuwenhuijzen JA, Knol RJJ, et al. Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical recurrence after curative radiotherapy. Eur Urol Oncol. 2021;4:821–5. https://doi.org/10.1016/j.euo.2020.01.002.

Article  PubMed  Google Scholar 

Tourinho-Barbosa RR, Wood BJ, Abreu AL, Nahar B, Shin T, Guven S, et al. Current state of image-guided focal therapy for prostate cancer. World J Urol. 2021;39:701–17. https://doi.org/10.1007/s00345-020-03254-4.

Article  PubMed  Google Scholar 

Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, et al. Blood prostate-specific antigen by volume of benign, Gleason Pattern 3 and 4 Prostate tissue. Urology. 2022;170:154–60. https://doi.org/10.1016/j.urology.2022.08.014.

Article  PubMed  Google Scholar 

Kotamarti S, Séguier D, Arcot R, Polascik TJ. Assessment after focal therapy: what is the latest? Curr Opin Urol. 2022;32:260–6. https://doi.org/10.1097/MOU.0000000000000988.

Article  PubMed  Google Scholar 

Oishi M, Gill IS, Tafuri A, Shakir A, Cacciamani GE, Iwata T, et al. Hemigland cryoablation of localized low, intermediate and high risk prostate cancer: oncologic and functional outcomes at 5 years. J Urol. 2019;202:1188–98. https://doi.org/10.1097/JU.0000000000000456.

Article  PubMed  PubMed Central  Google Scholar 

Kongnyuy M, Islam S, Mbah AK, Halpern DM, Werneburg GT, Kosinski KE, et al. PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients. World J Urol. 2018;36:209–13. https://doi.org/10.1007/s00345-017-2130-5.

Article  CAS  PubMed  Google Scholar 

Stabile A, Orczyk C, Giganti F, Moschini M, Allen C, Punwani S, et al. The role of percentage of prostate-specific antigen reduction after focal therapy using high-intensity focused ultrasound for primary localised prostate cancer. results from a large multi-institutional series. Eur Urol. 2020;78:155–60. https://doi.org/10.1016/j.eururo.2020.04.068.

Article  CAS  PubMed  Google Scholar 

Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. Prostate specific antigen criteria to diagnose failure of cancer control following focal therapy of nonmetastatic prostate cancer using high intensity focused ultrasound. J Urol. 2020;203:734–42. https://doi.org/10.1097/JU.0000000000000747.

Article  PubMed  Google Scholar 

Dickinson L, Ahmed HU, Hindley RG, McCartan N, Freeman A, Allen C, et al. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urol Oncol. 2017;35:30.e9–30.e15. https://doi.org/10.1016/j.urolonc.2016.07.015.

Article  CAS  PubMed  Google Scholar 

Khandwala YS, Morisetty S, Ghanouni P, Fan RE, Soerensen SJC, Rusu M, et al. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation. Urol Oncol. 2022;40:489.e9–489.e17. https://doi.org/10.1016/j.urolonc.2022.07.017.

Article  PubMed  Google Scholar 

Elshafei A, Tay KJ, Kara O, Malkoc E, Nyame Y, Arora H, et al. Associations between prostate volume and oncologic outcomes in men undergoing focal cryoablation of the prostate. Clin Genitourin Cancer. 2018;16:e477–e482. https://doi.org/10.1016/j.clgc.2017.10.009.

Article  PubMed  Google Scholar 

Marra G, Laguna MP, Walz J, Pavlovich CP, Bianco F, Gregg J, et al. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. Minerva Urol Nephrol. 2022;74:581–9. https://doi.org/10.23736/S2